Long Term Hemodialysis Catheters (LTHD) Post Market Clinical Follow up (PMCF)

NCT04782297 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-01-10

No results posted yet for this study

Summary

The primary objective of this observational PMCF study is to collect clinical data on the safety and efficacy of Medcomp Long Term Hemodialysis (LTHD) Catheter Kits in compliance with MDR 2017/745.

Conditions

Interventions

DEVICE

Long term hemodialysis catheter

There will be no interventions in this study. Strictly observational.

Sponsors & Collaborators

  • Syneos Health

    collaborator OTHER
  • Veeva Systems

    collaborator INDUSTRY
  • Medical Components, Inc dba MedComp

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-30
Primary Completion
2023-03-17
Completion
2023-03-17
FDA Device
Yes

Countries

  • United States
  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04782297 on ClinicalTrials.gov